end
begin
smallpox
vaccin
come
end
vaccinia
viru
poxvirus
set
becom
forgotten
famili
virus
surprisingli
develop
techniqu
allow
express
foreign
gene
vaccinia
viru
enjoy
someth
renaiss
inde
gener
vaccinia
recombin
almost
becom
cottag
industri
liter
hundr
foreign
gene
insert
express
viru
literatur
search
medlin
use
vaccinia
recombin
keyword
sinc
reveal
well
refer
vast
major
describ
one
vaccinia
recombin
describ
eukaryot
growth
factor
polymeras
ion
channel
tumour
marker
cell
surfac
protein
oncogen
bacteri
enzym
structur
protein
protozoan
surfac
protein
well
differ
viru
gene
product
famili
eukaryot
virus
express
vaccinia
recombin
widespread
use
vaccinia
viru
vector
owe
much
eas
gener
recombin
authent
foreign
gene
product
potenti
use
recombin
avail
exampl
gene
human
immunodefici
viru
siv
simian
immunodefici
viru
introduc
vaccinia
util
vector
system
illustr
express
envelop
glycoprotein
glycoprotein
fuse
posit
cell
assembl
higher
order
structur
cleav
transport
cell
surfac
featur
authent
glycoprotein
gp
express
vaccinia
antigen
indistinguish
authent
glycoprotein
recombin
fix
recombin
infect
cell
use
immun
anim
human
see
tabl
vi
vii
natur
cytotox
tcell
respons
specif
antibodydepend
cellular
cytotox
infect
also
analys
use
vaccinia
recombin
furthermor
varieti
recombin
express
variant
gener
order
studi
bind
glycosyl
oligomer
cleavag
antigen
alter
molecul
cleavag
also
shown
achiev
cellular
proteas
furin
demonstr
use
vaccinia
recombin
express
furin
gp
coinfect
cell
two
recombin
result
complet
cleavag
cleavag
could
also
inhibit
chloromethylketon
known
inhibitor
furin
possibl
use
vaccinia
recombin
live
vaccin
arous
great
deal
interest
controversi
idea
arisen
role
vaccinia
play
smallpoxerad
campaign
vaccinia
effect
vaccin
partli
due
eas
manufactur
low
cost
coupl
simplic
distribut
administ
recombin
vaccinia
virus
gener
express
antigen
deriv
pathogen
organ
mani
instanc
abl
protect
pathogen
exampl
vaccinia
recombin
express
rabi
viru
glycoprotein
protect
fox
racoon
skunk
challeng
rabi
viru
even
vaccin
present
bait
food
field
trial
recombin
use
bait
food
belgium
success
countri
set
similar
vaccin
programm
chapter
examin
improv
technolog
past
year
wide
varieti
experiment
use
recombin
put
progress
use
live
recombin
vaccin
base
pair
entir
sequenc
copenhagen
strain
much
wr
strain
avail
show
viru
approxim
dens
pack
gene
code
wide
varieti
gene
product
gene
rang
multigen
rna
polymeras
thymidin
kinas
dna
polymeras
uracil
dna
glycosylas
gene
homolog
illfj
receptor
even
gene
homolog
activ
similar
complement
control
protein
number
gene
involv
sever
differ
mechan
design
avoid
recognit
elimin
host
immun
system
review
ref
viru
particl
bricklik
oval
morpholog
compos
inner
dumbellshap
core
surround
outer
protein
coat
core
contain
mani
viruscod
enzym
allow
viru
synthes
function
cap
methyl
polyadenyl
mrna
vaccinia
templat
abil
along
viruscod
enzym
dna
polymeras
allow
viru
replic
exclus
cytoplasm
infect
cell
unlik
dna
virus
replic
nucleu
vaccinia
dna
noninfecti
viru
use
uniqu
regulatori
sequenc
appar
absenc
rna
splice
simplifi
construct
recombin
virus
express
foreign
gene
seri
plasmid
vector
develop
number
laboratori
avail
shown
fig
essenti
featur
basic
insert
vector
plasmid
vaccinia
promot
mrna
initi
site
devoid
translat
initi
site
adjac
conveni
restrict
enzym
site
flank
vaccinia
dna
often
vaccinia
viru
thymidin
kinas
tk
gene
gene
express
clone
one
restrict
enzym
site
whole
construct
transfer
vaccinia
viru
homolog
recombin
infect
cell
recombin
viru
transcript
start
authent
vaccinia
mrna
start
site
translat
initi
site
provid
foreign
gene
cdna
need
use
evid
vaccinia
splice
gene
origin
insert
vector
suffer
sever
limit
mainli
due
difficulti
identif
recombin
high
background
vector
insert
foreign
gene
vaccina
viru
vector
shown
insert
thymidin
kinas
tk
gene
viru
shade
box
indic
lefthand
l
righthand
r
region
tk
gene
arrow
indic
direct
transcript
variou
unit
promot
late
structur
gene
sll
k
engin
version
promot
promot
activ
dna
replic
intermedi
gene
promot
hind
iii
fragment
vaccinia
earli
promot
locat
within
invert
termin
repeat
vaccina
viru
j
bacteriophag
capsid
gene
promot
termin
gene
express
promot
direct
rna
polymeras
provid
second
recombin
viru
emcv
encephalomyocard
viru
ribosom
entri
site
bgal
e
coli
bgalactosidas
gene
allow
recombin
viru
detect
basi
coexpress
enzym
presenc
xgal
give
blue
plaqu
gpt
e
coli
guanin
phophoribosyltransferas
gene
confer
resist
mp
allow
recombin
express
gene
plaqu
presenc
mpa
smal
b
bamhi
k
kpni
site
restrict
endonucleas
indic
pata
gpt
origin
dr
h
stunneberg
laboratori
embl
heidelberg
often
excess
parent
wildtyp
nonrecombin
viru
tk
locu
use
tk
neg
phenotyp
use
select
recombin
abil
grow
presenc
howev
spontan
tk
mutant
aris
frequenc
dnabas
screen
distinguish
recombin
necessit
take
form
per
foreign
gene
dna
isol
singl
plaqu
southern
dna
isol
small
monolay
cell
infect
progeni
singl
plaqu
insert
nontk
site
origin
depend
screen
recombin
dna
howev
coinsert
vector
avail
allow
insert
marker
gene
gene
allow
domin
select
along
gene
interest
nonessenti
region
viru
genom
figur
show
coinsert
vector
use
either
escherichia
coli
figalactosidas
gpt
addit
less
frequent
use
method
gener
recombin
includ
coinsert
gene
interest
neomycin
resist
gene
select
coinsert
gene
interest
hygromycin
resist
gene
select
hygromycin
select
base
host
resist
gene
parent
viru
grow
particular
cell
line
plasmid
use
gener
recombin
restor
parent
viru
growth
properti
plaqu
morpholog
parent
viru
give
small
plaqu
phenotyp
restor
transfect
plasmid
site
insert
direct
vaccinia
dna
insert
vector
obvious
must
nonessenti
region
genom
infecti
viru
produc
sever
region
use
gener
recombin
includ
region
toward
left
hand
end
viru
genom
delet
mutant
intern
posit
within
hind
iii
f
fragment
wr
strain
viru
viru
haemagglutinin
gene
egf
homologu
gene
varieti
posit
see
ref
well
tk
gene
choic
insert
vector
crucial
determin
time
level
express
well
site
insert
vaccinia
viru
import
criteria
base
decis
use
recombin
put
may
necessari
make
recombin
sinc
transient
system
produc
reason
level
protein
may
requir
studi
protein
interest
high
level
express
requir
either
late
structur
promot
eg
kda
promot
system
use
condit
foreign
gene
express
late
promot
stimul
cellmedi
immun
act
target
cytotox
tcell
complic
express
foreign
gene
presenc
within
foreign
gene
code
sequenc
signal
termin
earli
gene
transcript
vaccinia
thu
gene
express
control
earli
promot
prematur
termin
occur
tttttnt
sequenc
protein
produc
two
sequenc
shown
termin
signal
mutat
conserv
code
sequenc
increas
level
gp
produc
earlyl
kda
promot
viru
produc
higher
level
antibodi
immun
mice
two
method
describ
allow
select
recombin
base
transient
express
marker
gene
first
method
describ
use
pgalactosidas
involv
flank
marker
gene
direct
repeat
plasmid
insert
vector
contain
kda
gene
drive
express
pgalactosidas
follow
promot
drive
measl
fusion
protein
gene
construct
recombin
fowl
poxvirus
isol
plaqu
presenc
xgal
recombin
repeat
poxvirus
highli
effici
passag
result
loss
pgalactosidas
recombin
viru
still
contain
measl
fusion
gene
recombin
express
second
gene
requir
pgalactosidas
could
use
marker
coselect
recombin
express
gene
second
method
refer
transient
domin
select
involv
construct
plasmid
transfer
vector
e
coli
gpt
vaccinia
viru
recombin
gene
link
promot
place
distal
vaccinia
viru
dna
contain
gene
interest
driven
second
promot
transfect
plasmid
infect
cell
mp
aresist
virus
select
resist
mp
acquir
singl
crossov
event
occur
see
fig
viru
contain
direct
repeat
site
insert
unstabl
passag
lose
similar
effici
depend
rel
length
dna
vaccinia
flank
gene
either
gpt
gene
whole
plasmid
dna
plaqu
screen
per
two
event
occur
major
advantag
final
viru
contain
e
coli
gpt
gene
therefor
may
use
sequenti
make
success
genom
alter
differ
loci
even
multipl
mutat
need
desir
circumst
marker
present
eg
viru
use
vaccin
use
situat
occur
virul
particular
virus
compar
sister
virus
recombin
wild
type
gener
parent
therefor
wild
type
viru
ideal
control
recombin
viru
method
use
elimin
e
coli
gpt
vaccinia
recombin
may
desir
domin
select
gpt
use
anoth
chromosom
locu
pseudowildtyp
viru
requir
control
recombin
delet
mutat
gene
method
reli
inabl
vaccinia
recombin
express
e
coli
gpt
plaqu
presenc
hypoxanthin
phosphoribosyltransferas
hprt
neg
line
need
use
plaqu
assay
hprt
incorpor
dna
toxic
event
plasmid
homolog
recombin
would
delet
gpt
transfect
cell
line
infect
gptexpress
viru
progeni
viru
screen
loss
gpt
simpli
plaqu
presenc
although
poxviru
dna
noninfecti
possibl
reactiv
denatur
poxvirus
homolog
heterolog
helper
poxvirus
phenomenon
report
decad
ago
fig
similar
use
phage
arm
follow
ligat
insertlibrari
packag
vitro
vaccinia
case
arm
vaccinia
packag
occur
vivo
due
helper
fowlpox
viru
advantag
system
elimin
need
clone
insert
vector
offer
potenti
clone
larg
fragment
toxic
vaccinia
viru
recombin
gene
could
clone
bacteria
well
possibl
gener
eukaryot
express
librari
kinet
level
express
foreign
gene
depend
primarili
promot
chosen
drive
express
gener
late
promot
structur
gene
stronger
earli
promot
kda
late
structur
gene
use
drive
fjgalactosidas
gene
yield
recombin
product
order
infect
cell
cultur
kda
promot
give
lower
level
fjgalactosidas
kda
promot
featur
vaccinia
viru
transcript
promot
see
ref
sever
vaccinia
promot
use
drive
foreign
gene
express
includ
kda
earli
promot
b
late
structur
promot
cowpox
inclus
bodi
protein
promot
sever
synthet
promot
eg
vast
major
gene
howev
express
earlyl
kda
promot
although
absolut
level
foreign
gene
product
vari
depend
mrna
protein
stabil
inform
avail
variou
promot
allow
time
express
approxim
level
product
chosen
signific
yield
around
lgl
case
protein
hivl
achiev
use
rna
polymeras
system
develop
moss
colleagu
two
virus
use
one
express
rna
polymeras
gene
contain
foreign
gene
control
promot
transcript
termin
express
foreign
gene
occur
cell
infect
virus
principl
use
two
virus
one
express
prokaryot
polymeras
second
contain
target
gene
control
appropri
promot
extend
bacteriophag
rna
polymeras
bacteriophag
rna
polymeras
similar
result
system
also
use
larg
scale
produc
hivl
ferment
contain
x
cell
microcarri
dualli
infect
rna
polymeras
recombin
recombin
hivl
gene
control
promot
fourstep
purif
protocol
mg
recov
yield
refin
system
improv
level
protein
produc
achiev
includ
ribosom
entri
sequenc
encephalomyocard
viru
emcv
untransl
leader
mrna
produc
promot
allow
capindepend
translat
mrna
circumv
difficulti
translat
uncap
mrna
produc
promot
one
case
foreign
gene
product
produc
account
total
cell
protein
basic
system
give
level
product
approxim
equal
deriv
kda
promot
howev
inclus
emcv
ribosom
entri
site
improv
level
factor
sever
laboratori
report
transfer
vector
simplifi
construct
recombin
second
type
control
express
deriv
prokaryot
transfer
vaccinia
unlik
system
induc
lac
repressor
oper
system
e
coli
incorpor
singl
viru
advantag
modif
allow
induc
express
foreign
gene
one
recombin
viru
gener
express
lac
repressor
contain
gene
interest
control
hybrid
lac
oper
vaccinia
promot
express
foreign
gene
induc
addit
iptg
cell
infect
virus
problem
taken
time
solv
incorpor
polymeras
gene
viru
contain
promot
reason
failur
clear
howev
problem
recent
solv
place
polymeras
control
weak
promot
use
lac
induc
system
induc
polymeras
express
requir
advantag
use
basic
twoviru
system
toxic
gene
express
exampl
vesicular
stomat
viru
vsv
gene
could
express
use
convent
vaccinia
vector
promot
replac
kda
promot
promot
allow
recombin
made
express
gene
dual
infect
cell
recombin
rna
polymeras
recombin
allow
otherwis
toxic
vsv
gene
express
analys
vaccinia
viru
recombin
express
bacteriophag
rna
polymeras
gene
use
extens
transient
assay
system
cell
infect
recombin
vaccinia
viru
express
rna
polymeras
gene
transfect
plasmid
contain
gene
interest
control
lo
promot
termin
rna
vaccinia
viru
recombin
polymeras
transcrib
gene
interest
input
plasmid
termin
termin
sequenc
suppli
plasmid
suffici
protein
made
transcript
allow
number
biolog
assay
undertaken
analysi
domain
involv
hiv
interact
undertaken
use
system
truncat
version
molecul
express
immunoprecipit
anti
antisera
truncat
molecul
abil
bind
identifi
bind
domain
map
region
studi
transport
associ
psslck
also
prove
fruit
vector
avail
without
emcv
ribosom
entri
site
improv
translat
foreign
gene
contain
transcript
number
integr
membran
protein
involv
ion
transport
also
express
transient
system
shown
produc
faith
biolog
activ
cystic
fibrosi
transmembran
conduct
regul
express
system
shown
correct
defect
chlorid
channel
regul
cystic
fibrosi
airway
epitheli
cell
impress
result
achiev
system
product
defect
vsv
particl
cotransfect
vaccinia
rna
polymeras
recombin
infect
cell
five
differ
vsv
gene
construct
requir
particl
form
system
also
advantag
one
recombin
viru
need
ie
rna
polymeras
viru
manipul
undertaken
plasmid
activ
mutat
gene
analys
without
time
consum
effort
make
virus
mutant
exampl
proteas
activ
gene
dengu
viru
type
studi
use
transient
system
seri
delet
mutant
assay
selfcleavag
junction
amino
acid
hydrophob
region
middl
gene
conserv
among
flavivirus
identifi
essenti
proteas
activ
predict
size
rule
undergo
faith
authent
posttransl
modif
glycosyl
proteolyt
cleavag
ycarboxyl
phosphoryl
myristil
foreign
gene
report
exampl
epsteinbarr
viru
ebv
vaccinia
recombin
infect
cell
ebv
transform
lymphocyt
glycosyl
similar
extent
bind
similar
molecular
weight
polyacrylamid
gel
except
report
modif
depend
cell
line
recombin
grown
enzym
produc
parent
organ
exampl
malaria
sporozoit
stage
major
surfac
antigen
express
vaccinia
gave
product
differ
size
authent
antigen
presum
posttransl
modif
parasit
carri
vast
major
foreign
protein
express
vaccinia
transport
normal
detect
appropri
subcellular
locat
nuclear
cytoplasm
cell
surfac
transport
well
secret
describ
strike
exampl
authent
transport
recombin
infect
cell
demonstr
correct
polar
transport
maintain
influenza
viru
haemagglutinin
direct
apic
surfac
recombin
infect
mdck
cell
wherea
murin
leukaemia
vsv
envelop
protein
direct
basolater
surfac
mdck
cell
protein
sequenc
determin
polar
express
particular
glycoprotein
also
investig
truncat
protein
friend
mink
cell
focu
induc
viru
follow
express
modifi
gene
vaccinia
reveal
polar
express
determin
portion
molecul
one
distinct
advantag
vaccinia
system
abil
express
genet
engin
gene
biolog
activ
variant
protein
studi
structur
function
relationship
establish
exampl
effect
mutat
singl
nlink
glycosyl
site
hiv
analys
laboratori
other
use
recombin
express
mutant
form
analysi
show
absenc
singl
glycosyl
site
diminish
complet
abolish
abil
hiv
fuse
posit
cell
carrol
unpublish
result
may
also
possibl
increas
immunogen
gene
product
simpl
modif
primari
code
sequenc
see
section
interact
molecul
express
vaccinia
recombin
also
studi
herp
simplex
viru
hsv
glycoprotein
gh
express
independ
hsv
either
vaccinia
recombin
express
system
trap
within
cell
suspect
anoth
hsv
glycoprotein
gl
act
chaperon
promot
correct
fold
transport
gh
express
gene
two
differ
recombin
coinfect
cell
shown
case
interact
grp
investig
role
protein
transport
fold
propos
case
bip
chaperon
endogen
express
vaccinia
recombin
haffar
et
ale
first
show
hivlik
particl
releas
recombin
vaccinia
viru
infect
cell
viru
express
hiv
gagpol
process
gag
protein
major
hiv
protein
found
celllys
although
small
amount
also
detect
cultur
medium
protein
analysi
viruslik
particl
purifi
medium
reveal
presenc
protein
absenc
revers
transcriptas
activ
electron
microscopi
releas
particl
reveal
diamet
nm
cylindr
core
structur
laboratori
also
report
detect
hivlik
particl
releas
vaccinia
viru
recombin
recombin
vacciniainfect
cell
line
subsequ
first
report
coexpress
hiv
gagpol
vaccinia
recombin
shown
produc
viruslik
particl
also
contain
particl
highli
immunogen
would
good
vaccin
candid
enough
materi
produc
viruslik
particl
also
gener
vaccinia
recombin
includ
human
papillomaviru
hpv
requir
transport
process
well
interact
molecul
analys
use
sitedirect
mutagenesi
express
gene
one
featur
vaccinia
viru
vector
system
infect
mani
cell
type
consequ
molecul
express
natur
context
even
highli
special
cell
type
neuron
muscl
cell
need
use
surprisingli
even
xenopu
oocyt
infect
vaccinia
recombin
produc
biolog
activ
protein
recent
year
larg
number
protein
involv
membran
excit
signal
across
membran
identifi
molecular
clone
express
use
vaccinia
viru
voltagedepend
ion
channel
neurotransmitt
gprotein
coupl
receptor
excit
protein
express
indic
possibl
studi
membran
protein
requir
cellspecif
posttransl
process
associ
cell
specif
subunit
well
protein
requir
coupl
endogen
second
messeng
pathway
full
biolog
activ
observ
abl
iv
show
divers
natur
enzymat
acnvm
express
vaccinia
viru
exampl
studi
adenoviru
dna
polymeras
termin
protein
ptp
hamper
low
abund
polymeras
ptp
well
presenc
adenoviru
infect
cell
complex
kda
viru
promot
overexpress
polymeras
ptp
separ
greater
adenoviru
infect
cell
combin
fulli
activ
initi
elong
adenoviru
dna
replic
system
vaccinia
recombin
also
use
studi
effect
enzym
inhibitor
eg
proteas
inhibitor
peptidomimet
proteinas
inhibitor
use
cell
infect
gagpol
recombin
proteas
part
pol
protein
respons
process
gag
precursor
primarili
without
inhibitor
repres
total
immunoreact
protein
use
sheep
antibodi
pm
reduc
level
total
immunoreact
protein
ie
inhibit
hivlik
particl
recov
inhibitortr
infect
cell
reveal
almost
exclus
trace
level
immunolog
applic
gener
monoclon
antibodi
sever
report
indic
possibl
gener
monoclon
antibodi
foreign
gene
product
immun
mice
vaccinia
viru
recombin
main
advantag
approach
present
antigen
nativ
form
possibl
induc
immun
respons
product
normal
present
small
amount
eg
viru
regulatori
protein
monoclon
antibodi
measl
fusion
protein
vsv
nucleoprotein
respiratori
syncyti
viru
produc
fashion
human
antihiv
monoclon
antibodi
also
made
transform
bcell
ebv
donor
vaccin
vaccinia
recombin
express
hiv
recombin
express
product
also
use
part
primari
screen
monoclon
antibodi
mcclean
colleagu
use
bacteri
fusion
protein
prime
mice
immunofluores
recombin
infect
cell
primari
screen
reactiv
although
rather
labori
method
advantag
use
primari
screen
procedur
antibodi
need
also
case
would
difficult
use
natur
sourc
protein
vaccinia
recombin
valuabl
determin
specif
cytotox
cell
ctl
rais
natur
experiment
infect
individu
gene
multigen
organ
express
vaccinia
recombin
use
target
ctl
classic
chromium
releas
assay
prove
possibl
abil
recombin
virus
express
foreign
antigen
surfac
vaccinia
viru
recombin
infect
cell
conjunct
major
histocompat
complex
molecul
cell
may
recogn
lyse
autolog
ctl
direct
foreign
antigen
review
see
ref
obvious
requir
process
foreign
antigen
appear
take
place
appropri
manner
interestingli
cell
infect
vaccinia
recombin
express
aminoacid
peptid
nucleoprotein
influenza
viru
lyse
ctl
specif
peptid
sequenc
exampl
util
vaccinia
recombin
seen
analysi
ctl
influenza
viru
individu
recombin
express
gene
influenza
viru
well
sever
engin
gene
gener
use
analys
ctl
respons
anim
human
recombin
help
establish
individu
previous
infect
influenza
recogn
matrix
polymeras
nucleoprotein
conjunct
mhc
class
antigen
furthermor
transfect
protocol
recombin
approach
indic
influenza
haspecif
ctl
induc
anim
mostli
non
crossreact
nucleoprotein
major
target
antiinfluenza
crossreact
ctl
recombin
express
truncat
gene
also
use
gener
target
ctl
either
use
bulk
cultur
tcell
clone
thu
specif
epitop
within
protein
gener
tcell
reactiv
identifi
case
env
gag
vif
nef
revers
transcriptasespecif
ctl
demonstr
infect
individu
number
epitop
recogn
tcell
clone
map
combin
use
peptid
vaccinia
recombin
express
truncat
gene
sinc
vaccinia
infect
broad
rang
cell
type
larg
varieti
infect
target
cell
may
test
cytotox
assay
even
studi
hla
restrict
analys
vaccinia
recombin
prime
stimul
cell
mediat
respons
foreign
gene
product
vaccin
anim
eg
influenza
ha
vaccinia
recombin
prime
ctl
mice
recogn
lyse
cell
express
ha
subtyp
type
experi
done
number
differ
virus
gener
respons
foreign
gene
parallel
respons
gene
natur
infect
normal
host
caution
requir
shown
tempor
regul
influenza
ha
express
vaccinia
affect
immun
respons
ha
produc
earli
late
infect
recogn
band
tcell
serv
target
ctl
wherea
ha
synthes
late
time
infect
recogn
ctl
topic
aspect
prime
demonstr
zaguri
immun
vaccinia
recombin
express
env
gene
restimul
vaccin
fix
recombin
infect
cell
demonstr
recombin
prime
atcel
mediat
respons
env
volunt
immun
env
recombin
stimul
sever
procedur
also
prime
tcell
respons
hiv
env
cell
individu
immun
vaccinia
recombin
express
hiv
gene
prolifer
respons
one
hiv
prepar
confirm
human
recombin
stimul
tcell
respons
sever
report
shown
possibl
analys
antibodydepend
cellular
cytotox
adcc
respons
use
vaccinia
viru
recombin
paper
use
recombin
infect
cell
target
adcc
manner
analog
work
done
cytotox
cell
recombin
infect
cell
express
env
gag
label
chromium
incub
sera
test
monitor
lysi
follow
incub
appropri
dilut
effector
cell
studi
shown
env
target
adcc
wherea
gag
specif
antibodydepend
cytotox
found
adcc
titr
patient
examin
correl
stage
hivrel
ill
neutral
antibodi
access
intracellular
viru
vaccin
stimul
antibodi
env
stimul
adcc
may
import
protect
cellassoci
viru
vaccinia
recombin
thu
use
reagent
determin
antigen
specif
adcc
recent
sever
recombin
describ
design
express
antigen
target
autoimmun
reaction
thu
anim
vaccin
viru
develop
autoimmun
technolog
may
valuabl
design
studi
possibl
therapeut
intervent
strategi
also
conceiv
antigen
allergen
could
express
vaccinia
use
design
experiment
model
allergi
case
recombin
gener
potenti
safeti
risk
one
would
wish
evalu
care
possibl
autoimmun
allergen
reaction
personnel
handl
virus
prefer
use
parent
viru
replic
human
cell
notion
recombin
vaccmia
virus
might
valu
live
vaccin
base
use
vaccinia
viru
smallpoxerad
campaign
impetu
evolut
approach
vaccin
given
recombin
vaccinia
virus
induc
neutral
antibodi
protect
anim
challeng
appropri
pathogen
tabl
v
viii
show
select
differ
recombin
virus
use
protect
experi
outcom
protocol
vaccinia
recombin
sever
advantag
vaccin
includ
cheap
vaccin
manufactur
eas
administr
stabil
without
refriger
potenc
singl
inocul
abil
stimul
humor
cell
mediat
immun
advantag
stem
flexibl
packag
capabl
vaccinia
particl
kbp
foreign
dna
accommod
without
compens
delet
genom
consequ
may
possibl
express
differ
antigen
protect
one
diseas
alreadi
shown
virus
express
three
differ
gene
construct
antibodi
three
foreign
protein
induc
vaccin
anim
also
possibl
elicit
respons
engin
gene
product
improv
antigen
see
section
abl
vii
summar
studi
use
poxviru
recombin
human
variou
immun
schedul
use
although
good
reason
optimist
longterm
use
recombin
seen
immun
induc
recombin
alon
probabl
suffici
confer
immun
hiv
combin
schedul
look
promis
altern
approach
improv
immunogen
describ
section
despit
advantag
consider
resist
use
vaccinia
recombin
primarili
low
level
welldocu
advers
reaction
vaccin
vaccinia
studi
million
vaccin
usa
hospit
nine
death
mani
less
sever
complic
attribut
vaccinia
problem
encount
rang
abnorm
skin
erupt
rare
disord
affect
central
nervou
system
sever
advers
reaction
vaccin
clearli
unaccept
compar
live
attenu
viru
vaccin
polio
measl
complic
rate
order
concern
also
express
use
live
vaccin
countri
high
rate
immun
suppress
due
hiv
infect
fear
dissemin
vaccinia
would
lifethreaten
report
ia
militari
recruit
vaccin
vaccinia
subsequ
die
shown
hivposit
sever
death
aid
patient
take
part
studi
use
fix
vaccinia
recombin
infect
cell
probabl
due
dissemin
vaccinia
incomplet
inactiv
viru
autoimmun
may
also
occur
unexpectedli
syrian
hamster
inocul
vaccinia
viru
express
rubella
viru
glycoprotein
develop
antipituitari
antibodi
anoth
reserv
complic
use
vaccinia
recombin
exist
immun
within
target
popul
consid
preexist
immun
vaccinia
well
express
antigen
replic
vaccinia
recombin
express
hsv
glycoprotein
gd
influenza
viru
haemagglutinin
inhibit
preexist
immun
either
hsv
influenza
suggest
preexist
immun
foreign
gene
express
recombin
unlik
problem
howev
exist
immun
vaccinia
like
decreas
replic
recombin
use
immun
henc
decreas
efficaci
recent
acquir
immun
vaccinia
shown
abolish
efficaci
mice
challeng
hsv
recombin
express
hsv
glycoprotein
gd
recombin
express
major
envelop
glycoprotein
ebv
use
volunt
china
shown
individu
previous
immun
vaccinia
fail
produc
antibodi
similarli
volunt
studi
usa
franc
individu
previous
immun
vaccinia
mount
antibodi
respons
hiv
express
vaccinia
recombin
vaccinia
naiv
individu
prime
hiv
evidenc
develop
tcell
prolif
respons
serum
antibodi
thu
although
prior
vaccin
problem
adult
less
problem
younger
age
group
routin
vaccin
ceas
year
ago
gener
experiment
protocol
use
small
anim
see
tabl
v
larg
dose
viru
use
manner
give
best
vaccinia
viru
recombin
immun
respons
possibl
although
establish
principl
vaccin
vaccinia
recombin
work
difficult
translat
practic
human
lower
efficaci
rate
report
primat
see
tabl
vi
due
valu
primat
investig
need
publish
experi
primat
reflect
real
difficulti
gener
protect
respons
possibl
due
fact
smaller
dose
viru
per
kilogram
bodi
weight
administ
reserv
use
vaccinia
viru
recombin
vaccin
provid
impetu
studi
possibl
way
attenu
viru
gene
involv
viru
pathogen
smallpox
erad
campaign
suffici
concern
complic
encourag
develop
attenu
vaccinia
strain
deriv
lister
vaccin
strain
licens
use
japan
viru
use
express
hepat
b
viru
surfac
antigen
similar
result
recombin
base
parent
strain
one
strain
test
eczemat
children
advers
effect
eczma
acknowledg
contraind
vaccin
vaccinia
mva
particularli
interest
strain
multipli
attenu
contain
six
major
delet
total
kbp
replic
human
cell
give
infecti
viru
use
vaccin
peopl
side
effect
report
recent
use
gener
recombin
past
attenu
strain
deriv
longterm
passag
tissu
cultur
consequ
gene
respons
attenu
case
mva
identifi
possibl
engin
specif
delet
insert
viru
genom
henc
provid
ration
approach
attenu
shown
inactiv
either
tk
gene
kda
epiderm
growth
factor
egf
homologu
gene
result
mark
reduct
pathogen
although
kda
virus
grow
well
tissu
cultur
give
poor
yield
fertil
hen
egg
probabl
attenu
use
vaccin
mani
tkminu
virus
base
laboratori
strain
wr
use
protect
experi
tabl
v
viii
howev
vaccin
strain
use
tk
minu
phenotyp
seem
drastic
fairli
poor
immun
respons
foreign
gene
report
tabl
vii
highli
attenu
vaccinia
viru
mutant
describ
esteban
colleagu
sever
lesion
delet
left
hand
end
genom
point
mutat
gene
control
plaqu
size
viru
perfectli
viabl
abl
induc
antibodi
respons
foreign
gene
express
viru
multipli
attenu
strain
nyvac
describ
shown
potenti
vaccin
howev
disadvantag
attenu
virus
tend
compromis
immun
respons
foreign
gene
longlast
protect
respons
probabl
requir
one
immun
therefor
necessari
balanc
advantag
attenu
possibl
benefit
reduct
complic
rate
potenti
decreas
efficaci
anoth
suggest
use
selfinactiv
vaccinia
virus
host
rang
gene
delet
gene
allow
replic
human
cell
virus
lack
gene
would
capabl
infect
cell
would
produc
infecti
viru
whether
virus
would
effect
vaccin
remain
seen
one
possibl
way
round
dilemma
express
gene
improv
immun
respons
decreas
complic
rate
sever
group
gener
recombin
express
ill
yinterferon
circumst
ill
recombin
induc
better
immun
respons
parent
viru
recombin
highli
attenu
respect
parent
virus
use
vaccin
immun
suppress
mice
pfu
wildtyp
viru
kill
nude
mous
wherea
mice
surviv
inocul
pfu
recombin
viru
vaccin
lesion
rhesu
squirrel
monkey
vaccin
recombin
much
smaller
equival
dose
wildtyp
viru
gener
coexpress
littl
effect
immunogen
foreign
gene
studi
suggest
inclus
lymphokin
may
make
possibl
use
vaccinia
recombin
immun
compromis
individu
even
protect
immun
elicit
less
risk
complic
vaccinia
possibl
circumst
improv
directli
immunogen
express
protein
exampl
hivl
cleav
vaccinia
viru
recombin
proteas
give
gp
express
vaccinia
viru
gp
much
less
immunogen
modifi
molecul
engin
delet
proteas
cleavag
site
probabl
due
anchor
membran
infect
cell
henc
present
effici
immun
system
infect
anim
anoth
exampl
improv
immun
respons
engin
product
express
vaccinia
recombin
anchor
secret
plasmodium
falciparum
gene
plasma
membran
immun
respons
gene
anchor
significantli
greater
gene
product
secret
exampl
analysi
antigen
engin
protein
fusion
foot
mouth
diseas
viru
fmdv
major
neutral
epitop
hepat
b
viru
core
antigen
express
use
vaccinia
recombin
fusion
protein
purifi
found
assembl
highli
immunogen
particl
anim
vaccin
particl
protect
challeng
fmdv
avenu
investig
might
also
prove
benefici
improv
immunogen
attenu
viru
exampl
attenu
insert
gene
complement
control
protein
homologu
serin
proteas
inhibitor
gene
kda
virokin
gene
may
posit
effect
immun
respons
vaccinia
protect
immunogen
inde
insert
kda
gene
attenu
viru
dramat
littl
effect
immunogen
viru
insert
serin
proteas
inhibitor
gene
improv
immun
respons
foreign
gene
fusion
protect
epitop
vaccinia
viru
structur
protein
may
produc
vaccinia
particl
incorpor
fusion
gene
structur
appear
achiev
pgalactosidas
fusion
well
kda
fusion
may
prove
valuabl
improv
immun
respons
foreign
gene
strategi
along
line
may
incorpor
foreign
gene
hybrid
protein
extracelluar
form
viru
form
import
gener
viru
neutral
antibodi
vivo
recent
sever
studi
use
vaccinia
recombin
express
hiv
prime
individu
follow
boost
either
paraformaldehydefix
recombinantinfect
pbl
purifi
see
tabl
vii
case
found
improv
level
circul
antibodi
result
tcell
respons
achiev
experiment
design
base
observ
mice
vaccin
mackett
vaccinia
recombin
express
hiv
follow
purifi
gave
better
respons
recombin
purifi
protein
use
primingboost
protocol
may
well
overcom
limit
immun
gener
subunit
hiv
vaccin
vaccinia
recombin
use
use
avipoxvirus
altern
vector
vaccmia
human
anim
vaccin
develop
approach
use
poxvirus
vaccinia
vaccin
combin
advantag
live
vaccin
infect
cell
present
peptid
via
major
histocompat
complex
safeti
advantag
kill
vaccin
undergo
full
replic
nonavian
speci
vaccin
poultri
use
fowlpox
pigeonpox
recombin
may
well
viabl
proposit
number
instanc
shown
protect
diseas
tabl
viii
canarypox
recombin
express
rabi
viru
g
protein
use
trial
human
nine
nine
individu
receiv
higher
dose
good
level
rabi
viru
neutral
antibodi
consid
immun
anim
debat
use
vaccinia
viru
vaccin
shift
problem
associ
sideeffect
vaccin
issu
spread
genet
engin
virus
environ
current
two
vaccinia
base
anim
vaccin
hold
potenti
one
protect
cattl
rinderpest
viru
protect
wildlif
rabi
viru
closest
widespread
use
vaccinia
recombin
express
rabi
viru
glycoprotein
shown
effect
field
situat
attempt
set
similar
trial
usa
initi
thwart
environment
lobbi
taken
bigger
scale
issu
spread
viru
human
popul
recombin
poxvirus
natur
detriment
effect
nontarget
anim
care
assess
suggest
member
poxviru
famili
might
make
suitabl
vector
anim
vaccin
attenu
vaccin
sheeppox
goatpox
fowlpox
see
section
canarypox
see
section
orf
viru
poxviru
sheep
use
vaccinia
viru
recombin
protect
pathogen
strain
respect
virus
attenu
virus
narrow
host
rang
therefor
advantag
spread
wide
environ
physic
organ
genom
mani
virus
determin
function
map
less
well
character
orthopoxvirus
might
also
use
vector
foreign
gene
exampl
raccoonpox
case
attract
raccoonpox
endem
area
usa
rather
use
vaccinia
viru
recombin
express
rabi
viru
glycoprotein
vaccin
wildlif
suggest
raccoonpoxvirusrabi
glycoprotein
recombin
may
efficaci
vaccin
raccoon
wild
although
poxvirus
use
vaccin
nearli
year
clear
potenti
vaccin
far
exhaust
recombin
vaccinia
virus
valuabl
laboratori
reagent
varieti
purpos
like
use
mani
year
come
trial
human
primat
partial
success
attempt
boost
specif
immun
taken
coupl
concern
complic
rate
immun
suppress
due
hiv
like
limit
use
vaccinia
recombin
human
howev
engin
attenu
express
lymphokin
fact
effect
hiv
vaccin
yet
develop
may
well
mean
approach
pursu
vigor
either
vaccinia
canarypox
recombin
concern
spread
genet
engin
virus
environ
could
limit
use
poxviru
base
vaccin
anim
although
good
reason
optimist
efficaci
final
analysi
like
complex
set
factor
polit
econom
sociolog
consider
play
larg
role
decis
whether
poxviru
recombin
use
vaccin
larg
scale
gagspecif
cytotox
lymphocyt
human
immunodefici
viru
type
linfect
individu
gag
epitop
cluster
three
region
protein
